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 Abstract 
 
Introduction: The study was designed to validate a Persian translate of 9-item Patient Health 
Questionnaire (PHQ-9) for screening depression in clinical setting. 
Method: It was a cross sectional study in two psychiatric clinics. 61 Major Depressive Disorder 
patients (according to Structural Clinical Interview for Diagnostic and Statistical Manual of Mental 
Disorders), and 61 without this diagnosis entred through convenience sampling. PHQ-9 was given 
to patients and controls. Intraclass correlation coefficient (ICC and paired T test),  Cronbach's alpha 
coefficient were calculated for test-retest reliability and internal consistency respectively. ROC 
curves were used to calculate sensitivity and specificity of the test. 
Results: According to the ROC curve results, PHQ-9 score equal or greater than 12 offers the 
greatest Youden Index for the diagnosis of major depression episode (MDE), with a  sensitivity and 
specificity of 80.3% and 78.7%, respectively. 
Conclusion: according to our study Persian type of PHQ-9 is a valid and reliable tool for 
diagnosing major deopressive episodes in clinical settings. It is usefull for detection of MDE 
severity as well.  
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       Introduction 
       Major depressive disorder is one of the 
most serious and disabling psychiatric 
disorders. Major depressive disorder can lead 
to medical problems, impaired individual 
functioning, reduced quality of life and 
mortality (1-3). The prevalence varies among 
different countries, this discrepancy depends 
on genetics, environmental parameters, racial 
factors, cultural differences in perceiving 
diagnostic parameters, psychometric 
characteristics of diagnostic tools and 
sampling protocol (3). The most common 
meticulous psychiatric disorder in IRAN is 
major depressive disorder with a 12-month 
prevalence of 12.7% (4). Major depressive 
episodes may happen during major depressive 
disorder (unipolar depression) and also in 
bipolar disorders both in type I and II .  
Despite the high prevalence in community, the 
rate of detection is very low in all types of 
depressive disorders so it seems to be 
reasonable to screen depression especially 
among populations who have risk factors for 
developing depression (5-7). According to 
existing literatures, usage of screening 
instruments have been proposed as a practical 
approach in primary care settings for the early 
detection of depressive disorders (8). In the 
1990s, a screening tool named Primary Care 
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Evaluation of Mental Disorders (PRIME-MD) 
was developed and validated for diagnosing 
some types of mental disorders such as, 
depressive, anxiety, somatoform, alcohol and 
eating disorders (9). Additionally, a self-
directed form of PRIME-MD named, Patient 
Health Questionnaire (PHQ) was developed 
for early detection of mental health disorders 
(10, 11). PHQ-9, GAD-7 and PHQ-15 are 
three types of PHQ for diagnosis and assessing 
depression, anxiety disorders and somatic 
symptom severity respectively (12-14).  
PHQ-9 is made up of nine questions according 
to DSM-IV criteria of major depressive 
episode (15). It’s validity for diagnosis of 
depression has been proven in many clinical 
settings including primary (10, 11, 16, 17) and 
also non-psychiatric (dialysis, cardiology, 
stroke, diabetes and nephrology) care settings 
(18-23). This diagnostic tool has been used for 
diagnosis of depression among different racial 
and ethnic populations in United States (24). 
Also, it has been validated in many languages 
including portuguese (25), german (26, 27), 
dutch (28, 29), thai (30), malay (31) and 
konkani (32). 
The Beck Depression Inventory is an 
instrument commonly used for depression 
screening and is translated to Persian (33). 
PHQ-9 is the best instrument for screening of 
depression in primary care settings because of 
its shortness and simplicity. It can diagnose 
depression and measure its severity, so it is 
suitable for monitoring the treatment process 
as well (34). 
It has been shown that PHQ-9 has a sensitivity 
of 88% and a specificity of 88% for 
diagnosing major depression, these two 
excellent properties besides criteria based 
ability to diagnosis, make PHQ-9 a very 
suitable test for clinical and research purposes 
(15). 
The aim of this study was to assess the 
reliability and validity of the Persian version 
of  the PHQ- 9 screening scale in a clinical 
setting in Iran. 
 
    Methods 
 Participants 
61 patients with the major depressive disorder 
diagnosis, and 61 without major depressive  
diagnosis were recrutied  from psychiatry 
wards of Imam Hossein and Taleghani 
hospitals in Tehran, through convenience 
sampling.  
Inclusion criteria included individuals between 
18 and 64 years old, while the exclusion 
criteria were having psychosis, cognitive 
impairment or mental retardation.  
All patients were selected from patients of the 
psychiatry ward in their first day of admission 
while controls were entered from psychiatric 
outpatient clinic. All the subjects were 
interviewed according to SCID (Structural 
Clinical Interview for Diagnostic and 
Statistical Manual of Mental Disorders) by a 
psychiatrist to diagnose major depressive 
episode. After the psychiatric interview, PHQ-
9-SR was given to patients with the diagnosis 
of major depressive episode and the controls. 
SCID has been validated earlier in Iran (35). 
Before presenting the participants with the 
questionnaire, we made sure that all subjects 
have a writing tool and they were helped to 
stay mentally relaxed. Then they rendered a 
written consent and were given a version of 
PHQ-9-SR along with a demographic 
questionnaire. All of the subjects were 
checked to be able to read the questionnaire 
and had understood that she/he had to read 
every question carefully and then choose the 
correct answer. Each subject was asked to 
choose the closest answer if she/he is not 
totally sure about it and not to left any 
question without answer. Before taking back 
the filled questionnaires, the subjects were 
asked if they had encountered any vague 
question; besides, the questionnaires were 
controlled to check that all questions were 
answered.  
To examine test-retest reliability, 30 of the 
subjects were asked to answer the self-report 
scale again after two weeks. In order to assess 
the patient subjects, psychiatrists interviewed 
61 subjects diagnosed with Major Depressive 
Episode.  
In this part of the research, findings of PHQ-9 
were compared to the clinical findings based 
on SCID-I as standard criterion, and 
psychometric characteristics, sensitivity, 
specificity, false positive and false negative 
were calculated.  
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To respect ethical rules, the aim of research 
and its confidentiality was explained for the 
participants and their consent were taken. 
Besides, treatment was begun for the patients 
diagnosed with MDE.  
Data analysis was done with the help of SPSS-
21 software. To calculate test-retest reliability, 
intraclass correlation coefficient (ICC and 
paired T test); and to assess internal 
consistency, Cronbach's alpha coefficient were 
used. Finally, ROC curves were used to 
calculate sensitivity and specificity of the test. 
Instruments 
The main applied tool was PHQ-9 which 
contains 9 items assessing symptoms 
mentioned in DSMIV TR (loss of interest, 
depressed mood, sleep distuebances, reduced 
energy, change in appetite, worthlessness or 
guilt feeling, problem in memory and 
cocentration, psychomotor retardation or 
aggitation and recurrent thoughts of death or 
suicide), and one item assessing function. 
Assessment scale of major depressive episode 
has been drawn from a 3-page questionnaire 
called PRIME-MD. Filling this version, takes 
3 minutes in 85% of cases and takes 5 minutes 
in 15% of them (10). PHQ-9 is a self-report 
questionnaire, but if needed, the items can be 
read for the participants (9). It is necessary to 
remind that all items must be answered in one 
session.  
At first, It is translated to the English version 
of PHQ-9-SR to Persian by a bilingual 
psychiatrist. Afterwards, it was translated back 
to English by another bilingual person (not a 
psychiatrist). This English translation was 
compared and adopted to the original version 
by two psychiatrists, and then a poll was 
conducted among 10 patients referred to 
psychiatric clinic about fluency and 
intelligibility of the translation whose result 
presented no ambiguity in the translated 
version. Validity of the translated sentences 
was approved by five faculty member 
psychiatrists from psychiatric department of 
Shahid Beheshti University of Medical 
Science. 
Personal information of patiens and controls 
were collected in the demographic 
questionaire.  
 
    Results 
Table 1.  Demographic characteristics of the sample are 
shown in  
Table 1. Demographic characteristics of the study 
sample (N=62) 
Characteristics No. % 
Sex   
  Female 62 50.8 
  Male 60 49.2 
Age mean ±SD; Range  34.6 ±10.8; 18-61 
Education   
  Primary 20 10.9 
  Guidance 33 17.9 
  High school 47 25.5 
Bachelor and  above 23 11.5 
Diagnoses   
  Bipolar I 28 15.2 
  Bipolar II 12 6.5 
  MDD 21 11.4 
For a statistical analysis and test-retest  
measurementreliability,intraclass 
correlation coefficient was used. 
ICC was more than 0.70 for 9 questions and 
paired T test also showed no significant 
differences (table 2).  
 
Table 2: pretest-posttest correlation for each question of Persian PHQ-9 
Question no Mean score before Mean score after Correlation ICC* P value 
1 2.8 ± 0.4 1.8 ± 0.9 .558 0.744 .655 
2 2.5 ± 0.6 1.5 ± 1 .689 0.816 .414 
3 2.1 ± 0.7 1.5 ± 0.9 .729 0.843 .705 
4 2.5 ± 0.6 1.6 ± 1 .744 0.744 .414 
5 2.2 ± 0.6 1.3 ± 1 .668 0.668 .705 
6 2.3 ± 0.7 1.2 ± 1 .741 0.732 .414 
7 2.4 ± 0.6 1.3 ± 1 .716 0.715 .257 
8 2.2 ± 0.7 1 ± 1 .767 0.751 .414 
9 2.4 ± 0.6 1 ± 1 .848 0.838 .025 
      * Intra-class correlation coefficient 
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Besides, in order to analyze the internal 
consistency, Cronbach's alpha was calculated 
for all 9 questions which presented 0.91 to 
0.93 for all of them (table 3).  
 
Table no 3: Cronbach's Coefficient Alpha and Item-total 
correlation for each of questions of Persian PHQ-9. 
Question no. Cronbach's 
alpha 
Item-total 
correlation 
1 .912 .812 
2 .918 .713 
3 .925 .593 
4 .916 .737 
5 .918 .714 
6 .911 .816 
7 .916 .746 
8 .916 .737 
9 .919 .697 
 
We then draw ROC curve for PHQ-9 results 
for diagnosing major depressive 
episode(Figure1). 
 
 
For calculating sensitivity and specificity with 
the confidence interval of 95%, after drawing 
ROC curve for different cut-off points in every 
9 question, the highest sensitivity and 
specificity was found to belong to question 6 
with AUC:0.864 and the lowest sensitivity and 
specificity was found to belong to question 7 
with AUC:0.723 .  
According to the ROC curve results, PHQ 
equal or greater than 12 offers the greatest 
Youden Index for the diagnosis of MDE, with 
a  sensitivity and specificity of 80.3% and 
78.7%, respectively. 
In table 4 the sensitivity and 1-specificity of 
various PHQ-9 cut off points for diagnosing 
major depressive episode that have been 
illustrated. Often, Youden index is used to 
determine the best cut off point in the 
screening questionnaires. As is shown PHQ-9 
score equal or greater than 12 offers the 
greatest Youden Index for the diagnosis of 
MDE (major depressive episode).  
 
Table 4: Sensitivity and 1-specificity of various PHQ_9 
cut off points for Major 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depressive Episode 
diagnosed by 
SCID.Cut off score  
(Than or Equal To) 
 Sensitivity    1 – Specificity 
.5 1.000 .951 
1.5 1.000 .902 
2.5 1.000 .820 
3.5 .984 .738 
4.5 .967 .672 
5.5 .951 .623 
6.5 .951 .557 
7.5 .934 .508 
8.5 .902 .443 
9.5 .869 .328 
10.5 .852 .295 
11.5 .836 .246 
12.5 .803 .213 
13.5 .754 .180 
14.5 .705 .131 
15.5 .656 .098 
16.5 .607 .016 
17.5 .557 .016 
18.5 .508 0.000 
19.5 .361 0.000 
20.5 .279 0.000 
21.5 .197 0.000 
22.5 .164 0.000 
23.5 .082 0.000 
24.5 .049 0.000 
25.5 .033 0.000 
26.5000 .016 0.000 
28.0 0.000 0.000 
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A comparison between scores of all 9 
questions in patients group and control group 
showed that there is a significant difference 
among the scores of two groups. The greatest 
difference belonged to question 1 which 
assesses patient's mood regarding depression 
and decreased pleasure. It means score was 2 
and the Inter quartile range (IQR) was 
obtained as 2-3 in patients groups and 1-2 in 
control group. The least difference belonged to 
question 9 which assesses death wish, self-
harm and suicidal ideation. It means score was 
1 and the IQR was obtained as 1-2 in patients 
group and 5-1 in controling group. Among 
subjects of controling group without major 
depressive episode, through SCID-I interview, 
41 subjects were diagnosed with other 
depressive disorders, and 20 subjects had no 
kind of depressive disorder. In order to 
dissociate the cut-off point between the two 
groups with the confidence interval of 95%, 
under-curve are for all 9 questions, was less 
than 0.6 which shows the questionnaire's low 
ability in discriminating between minor 
depression and lack of depression in the 
subjects.  
PHQ-9-SR gives two groups of scores 
(subscales) which are “Major Depressive 
symptoms” and “impaired function” in 
patients. A significant statistical correlation 
between general assessment of functioning 
(GAF) and disease impact was yeilded with P-
value<0.01 and i=0.71. According to the 
curve, more than 60% of subjects, in GAF 
higher than 71-80 (impact 1&2)  and in 1-10 
GAF, had chosen too-much-difficulty in the 
questionnaire and with the improvement of 
GAF the difficulty level would be reduced.  
 
    Discussion 
    According to the ROC and AUC cure of this 
study, PHQ-9 Persian version was suitable for 
diagnosis major depressive episode. 
To our knowledge, this research was the first 
report of psychometric characteristics of 
patient health questionnaire 9, self-report 
version (PHQ-9-SR). One-week test-retest 
reliability revealed that correlation of all 
scores in two performance of the questionnaire 
has been higher than 0.70 ,which correlates 
with the outcome of the study on English 
version of the scale (correlation of 0.7-0.8).  
A self-report questionnaire is considered 
reliable only if the Cronbach’s alpha is equal 
or more than 0.70 (36). In our study the 
Cronbach’s alpha was 0.9, which means an 
appropriate internal consistency similar to 
surveys accomplished in United States 
(Cranach’s alpha = 0.7-0.89) (24, 37) and 
Thailand (Cronbach’s alpha=0.79) (30). 
Like the study that was conducted by Kronke 
et al., (15) in this study the participants in both 
groups were assessed by SCID1. 
The cutoff point in our study was 12 with the 
sensitivity of 80.3% and specificity of 78.7%, 
while in Kronke study the cutoff point was 15 
for diagnosis of major depressive episodes the 
sensitivity and specificity were 87% and 82% 
respectively (15). A test with sensitivity of 79-
97% and specificity of 63-86% is considered 
acceptable for screening test (38), so Persian 
version of PHQ-9 is a satisfactory screening 
test. In other studies for PHQ-9 validation, the 
obtained cut-off points were for depression as 
a general syndrome not for Major Depressive 
Episode (39).  
One of the strength of this study was that 
besides determining the PHQ-9 cutoff for 
diagnosing major depressive episodes, this 
scale can be used to determine the severity of 
major depressive episodes. Also we used for 
validation SCID-1 as the gold standard, which 
has a high rate of validity and consistency 
(35). 
To determine the major depressive episode at 
the cut-off point of 12, satisfactory sensitivity 
and specificity were obtained (80.3% and 
78.7% respectively). However; this 
questionnaire was unable to screen minor 
depression from healthy state. Besides, the 
lowest mean score in each group belonged to 
question 9 (Thoughts that you would be better 
off dead or of hurting yourself in some way), 
this may point out the independency of 
suicidality from depression. The highest mean 
score in patients group belonged to question 1 
(Little interest or pleasure in doing things). It 
means that question one (lack of pleasure or 
anhedonia) is prerequisite for diagnosis of 
major depressive episode in DSM-IV-TR. The 
least sensitivity and specificity belonged to 
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question 7 (Trouble concentrating on things, 
such as reading the newspaper or watching 
television) which is not specific for depression 
and can be observed in other disorders as well. 
The highest sensitivity and specificity 
belonged to question 6 (Feeling bad about 
yourself - or that you are a failure or have let 
yourself or your family down) which is one of 
the diagnostic symptoms of depressive 
disorder and is more specific than other 
symptoms.  
The Persian version of questionnaire was able 
to measure depression severity. This makes it a 
suitable tool for comparing different patients 
suffering from major depressive episodes and 
evaluating patients longitudinally for example 
during treatment fallow ups.  
In this survey we evaluated the correlation 
between Persian PHQ-9 and the Global 
Assessment of Functioning (GAF). The score 
of PHQ-9 was negatively correlated with GAF 
in both MDE and non MDE groups (p<0.001). 
It means Persian PHQ-9 can discriminate 
patients with major depressive episode from 
ones without, and also this differentiation is 
functionally meaningful.  
According to our study Persian version of 
PHQ-9 was not able to separate depressive 
states other than MDE from normal because 
the controls were someone who may be 
normal or suffer from mild depression such as 
minor depressive episode. 
Although we yielded a cutoff point with 
acceptable sensitivity and specificity, this 
cannot be used for estimating predictive 
values. The reason is that the participants were 
selected from clinical settings and not from 
community.  
Like other self-report tools, PHQ-9 is subject 
to several limitations, for instance gender and 
cultural differences may affect the answering. 
Random answering and insufficient motivation 
would cause prejudice; as well sometimes 
subjects try to present themselves better. All of 
these facts are considered as the limitations of 
the present research.  
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